Sep 2026
Computational identification of isoflavonoids as novel PPAR-γ agonists for the treatment of type 2 diabetes mellitus.
BackgroundThe management of type 2 diabetes mellitus (T2DM) using peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists is currently limited by the adverse effects of thiazolidinediones (TZDs), such as fluid retention and weight gain. This necessitates the search for safer natural alternatives.MethodsThis...
Abdulkadir Abdu, Hossamaldeen Bakreys, E. M. Abdulkareem et al.
· Technology and Health Care · 0 citations